| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |